Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 14 8 2020
medline: 31 3 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

Personal protective equipment (PPE) is a critical need during the coronavirus disease 2019 (COVID-19) pandemic. Alternative sources of surgical masks, including 3-dimensionally (3D) printed approaches that may be reused, are urgently needed to prevent PPE shortages. Few data exist identifying decontamination strategies to inactivate viral pathogens and retain 3D-printing material integrity. To test viral disinfection methods on 3D-printing materials. The viricidal activity of common disinfectants (10% bleach, quaternary ammonium sanitizer, 3% hydrogen peroxide, or 70% isopropanol and exposure to heat (50°C, and 70°C) were tested on four 3D-printed materials used in the healthcare setting, including a surgical mask design developed by the Veterans' Health Administration. Inactivation was assessed for several clinically relevant RNA and DNA pathogenic viruses, including severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human immunodeficiency virus 1 (HIV-1). SARS-CoV-2 and all viruses tested were completely inactivated by a single application of bleach, ammonium quaternary compounds, or hydrogen peroxide. Similarly, exposure to dry heat (70°C) for 30 minutes completely inactivated all viruses tested. In contrast, 70% isopropanol reduced viral titers significantly less well following a single application. Inactivation did not interfere with material integrity of the 3D-printed materials. Several standard decontamination approaches effectively disinfected 3D-printed materials. These approaches were effective in the inactivation SARS-CoV-2, its surrogates, and other clinically relevant viral pathogens. The decontamination of 3D-printed surgical mask materials may be useful during crisis situations in which surgical mask supplies are limited.

Sections du résumé

BACKGROUND
Personal protective equipment (PPE) is a critical need during the coronavirus disease 2019 (COVID-19) pandemic. Alternative sources of surgical masks, including 3-dimensionally (3D) printed approaches that may be reused, are urgently needed to prevent PPE shortages. Few data exist identifying decontamination strategies to inactivate viral pathogens and retain 3D-printing material integrity.
OBJECTIVE
To test viral disinfection methods on 3D-printing materials.
METHODS
The viricidal activity of common disinfectants (10% bleach, quaternary ammonium sanitizer, 3% hydrogen peroxide, or 70% isopropanol and exposure to heat (50°C, and 70°C) were tested on four 3D-printed materials used in the healthcare setting, including a surgical mask design developed by the Veterans' Health Administration. Inactivation was assessed for several clinically relevant RNA and DNA pathogenic viruses, including severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human immunodeficiency virus 1 (HIV-1).
RESULTS
SARS-CoV-2 and all viruses tested were completely inactivated by a single application of bleach, ammonium quaternary compounds, or hydrogen peroxide. Similarly, exposure to dry heat (70°C) for 30 minutes completely inactivated all viruses tested. In contrast, 70% isopropanol reduced viral titers significantly less well following a single application. Inactivation did not interfere with material integrity of the 3D-printed materials.
CONCLUSIONS
Several standard decontamination approaches effectively disinfected 3D-printed materials. These approaches were effective in the inactivation SARS-CoV-2, its surrogates, and other clinically relevant viral pathogens. The decontamination of 3D-printed surgical mask materials may be useful during crisis situations in which surgical mask supplies are limited.

Identifiants

pubmed: 32783787
pii: S0899823X20004171
doi: 10.1017/ice.2020.417
pmc: PMC7463154
doi:

Substances chimiques

DNA, Viral 0
Disinfectants 0
RNA, Viral 0
Hydrogen Peroxide BBX060AN9V
2-Propanol ND2M416302

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-260

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES005605
Pays : United States
Organisme : BLRD VA
ID : I01 BX000207
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129269
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI060699
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007343
Pays : United States

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
3D Print Med. 2016;2:
pubmed: 29974058
Virol J. 2013 Sep 15;10:289
pubmed: 24034697
J Mol Biol. 2020 May 1;432(10):3309-3325
pubmed: 32320687
Materials (Basel). 2020 Jan 09;13(2):
pubmed: 31936429
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Anaesthesia. 2020 Aug;75(8):1022-1027
pubmed: 32348561
Anal Chem. 2014 Apr 1;86(7):3240-53
pubmed: 24432804
mBio. 2020 Feb 11;11(1):
pubmed: 32047128
J Virol. 1991 Sep;65(9):5029-36
pubmed: 1651421
J Infect Dis. 2017 Nov 27;216(9):1164-1175
pubmed: 28968905
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Infect Control Hosp Epidemiol. 1999 Dec;20(12):821-7
pubmed: 10614606
World Neurosurg. 2013 Sep-Oct;80(3-4):233-5
pubmed: 23871811
3D Print Med. 2020 Apr 27;6(1):11
pubmed: 32337613
Adv Drug Deliv Rev. 2017 Jan 1;108:39-50
pubmed: 27001902
Materials (Basel). 2020 Mar 19;13(6):
pubmed: 32204456
Science. 2020 May 8;368(6491):
pubmed: 32234805
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Biomed Eng Online. 2016 Oct 21;15(1):115
pubmed: 27769304
Lab Med. 2020 Jul 8;51(4):e45-e46
pubmed: 32386057
J Virol Methods. 2017 Aug;246:51-57
pubmed: 28359770
Materials (Basel). 2020 Apr 24;13(8):
pubmed: 32344688
Sci Rep. 2021 Jan 21;11(1):2051
pubmed: 33479334
J Virol Methods. 2014 Oct;207:232-7
pubmed: 25025814
3D Print Med. 2018 Nov 21;4(1):11
pubmed: 30649688
J Immunol. 2010 Oct 1;185(7):4496-505
pubmed: 20826757
mBio. 2020 May 5;11(3):
pubmed: 32371599
Sci Total Environ. 2020 Jul 10;725:138532
pubmed: 32304970
Pharmaceutics. 2019 Aug 03;11(8):
pubmed: 31382565

Auteurs

Jennifer L Welch (JL)

Medical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.
Department of Internal Medicine, Carver College of Medicine University of Iowa, Iowa City, Iowa.
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Jinhua Xiang (J)

Medical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.
Department of Internal Medicine, Carver College of Medicine University of Iowa, Iowa City, Iowa.
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Samantha R Mackin (SR)

Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Stanley Perlman (S)

Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Peter Thorne (P)

Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa.

Patrick O'Shaughnessy (P)

Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa.

Brian Strzelecki (B)

VA Puget Sound Health Care System, Seattle, Washington.

Patrick Aubin (P)

Center for Limb Loss and MoBility (CLiMB), VA Puget Sound Health Care System, Seattle, Washington.
Department of Mechanical Engineering, University of Washington, Seattle, Washington.

Monica Ortiz-Hernandez (M)

Center for Limb Loss and MoBility (CLiMB), VA Puget Sound Health Care System, Seattle, Washington.
Department of Mechanical Engineering, University of Washington, Seattle, Washington.

Jack T Stapleton (JT)

Medical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.
Department of Internal Medicine, Carver College of Medicine University of Iowa, Iowa City, Iowa.
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH